Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Descriptive Canadian, Multicenter, Open-label, Randomized Study of Two Titration Algorithms With Insulin Glargine 300 Units/mL in Type 2 Diabetes Mellitus Patients

NCT02401243 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT02401243
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02401243 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Descriptive Canadian, Multicenter, Open-label, Randomized Study of Two Titration Algorithms With Insulin Glargine 300 Units/mL in Type 2 Diabetes Mellitus Patients
Lead sponsor
Sanofi
Phase
Phase 3
Overall status
Completed
Start date
March 31, 2015
Completion date
February 29, 2016
Enrollment
253 (actual)
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes mellitus